CCR9 and breast cancer: Crystal, Johnson-Holiday et al. (2011) reported that the CCR9/CCL25 axis could induce different types of matrix metalloproteinases in breast cancer cells, and various MMPs promote the degradation of the extracellular matrix, thus creating favorable conditions for the invasion and metastasis of breast cancer cells.